Catalent to Expand Its Biologics Analytical Services with New Facility in Durham

New Jersy-based Catalent, the global leader in enabling biopharma, cell, gene, and  consumer health partners to optimize development, launch, and supply of  better patient treatments across multiple modalities, today announced  that it is to establish a new biologics analytical center of excellence  in Durham, within North Carolina’s Research Triangle, to offer  comprehensive standalone analytical development and testing for biologic  drug modalities, including cell and gene therapies.

Author: Mike Jackson